FIELD: pharmaceuticals.
SUBSTANCE: invention relates to carbapenem compounds, stereoisomers, pharmaceutically acceptable salts thereof, suitable for treating bacterial infections, in particular, medication-resistant bacterial infections, as well as pharmaceutical compositions containing such compounds and application thereof in the treatment of a bacterial infection.
EFFECT: creation of carbapenem compounds suitable for treating bacterial infections.
28 cl, 1 tbl, 601 ex
Title | Year | Author | Number |
---|---|---|---|
2-THIOSUBSTITUTED CARBAPENEMS, INTERMEDIATE COMPOUNDS FOR SYNTHESIS, METHODS OF SYNTHESIS (VARIANTS), PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2130457C1 |
CEPHALOSPORIN DERIVATIVES AND PHARMACEUTICAL AGENT | 1994 |
|
RU2130939C1 |
CONDENSED SUBSTITUTED AMINOPYRROLIDINE DERIVATIVE | 2007 |
|
RU2443698C2 |
COMPOSITIONS AND METHODS FOR INHIBITING VIRAL POLYMERASE | 2013 |
|
RU2654482C2 |
SUBSTITUTED 3-AMINOQUINUCLIDINES | 1992 |
|
RU2092486C1 |
MELANOCORTIN RECEPTOR AGONISTS | 2007 |
|
RU2411240C2 |
NEW BIPHENYL COMPOUND OR ITS SALT | 2016 |
|
RU2726622C2 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2786722C1 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
Authors
Dates
2022-05-27—Published
2017-03-15—Filed